Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome; Randomized Controlled Study

NCT07421427 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07421427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome; Randomized Controlled Study
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2026
Completion date
January 1, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amantadine, duloxetine, mastectomy, pain syndrome, pregabalin